Healthcare -
Biotechnology - NASDAQ - GB
$ 11.311
-0.519 %
$ 8.23 B
Market Cap
2.04
P/E
ROIV - COST OF REVENUE
Cost of Revenue ROIV - Roivant Sciences Ltd.
28 M
LAST VALUE
76.60%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR